See every side of every news story
Published loading...Updated

Genocea Biosciences (NASDAQ:GNCA) Research Coverage Started at StockNews.com

Summary by modernreaders.com
StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report released on Wednesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance Genocea Biosciences has a twelve month low of $0.00 and a twelve month high of $0.00. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.35 and a quick ratio of 1.35. The stock has a ma…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

modernreaders.com broke the news in on Saturday, March 29, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.